GTx, Orion, Kyowa Hakko Kirin sales and marketing update
GTx and Orion terminated an expanded 2000 deal granting GTx exclusive, worldwide rights to toremifene for all indications in the U.S. and
Gathering data...
GTx and Orion terminated an expanded 2000 deal granting GTx exclusive, worldwide rights to toremifene for all indications in the U.S. and